Johnson, D. B., Estrada, M. V., Salgado, R., Sanchez, V., Doxie, D. B., Opalenik, S. R., . . . Balko, J. M. (2016). Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nature communications, 7(1), 10582-10. https://doi.org/10.1038/ncomms10582
Citace podle Chicago (17th ed.)Johnson, Douglas B., et al. "Melanoma-specific MHC-II Expression Represents a Tumour-autonomous Phenotype and Predicts Response to Anti-PD-1/PD-L1 Therapy." Nature Communications 7, no. 1 (2016): 10582-10. https://doi.org/10.1038/ncomms10582.
Citace podle MLA (9th ed.)Johnson, Douglas B., et al. "Melanoma-specific MHC-II Expression Represents a Tumour-autonomous Phenotype and Predicts Response to Anti-PD-1/PD-L1 Therapy." Nature Communications, vol. 7, no. 1, 2016, pp. 10582-10, https://doi.org/10.1038/ncomms10582.